These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35095077)

  • 1. Implications of Heart Rate in Patients with Left Ventricular Assist Devices.
    Imamura T; Kinugawa K; Narang N; Nishida H; Pinney S; Jeevanandam V; Ota T
    Int Heart J; 2022; 63(1):56-61. PubMed ID: 35095077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Implications of Mitral Valve Inflow Pattern Overlap during Ivabradine Therapy.
    Imamura T; Hori M; Narang N; Besser S; Kinugawa K
    Int Heart J; 2022; 63(1):43-48. PubMed ID: 35095075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study).
    Fu M; Ahrenmark U; Berglund S; Lindholm CJ; Lehto A; Broberg AM; Tasevska-Dinevska G; Wikstrom G; Ågard A; Andersson B;
    Clin Res Cardiol; 2017 Dec; 106(12):960-973. PubMed ID: 28795299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronotropic Assessment in Patients with Constrictive Pericarditis.
    Imamura T; Narang N; Besser S; Kinugawa K
    Int Heart J; 2021 Jul; 62(4):811-815. PubMed ID: 34234074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of optimal heart rate on left ventricular reverse remodeling and functional improvement in patients with systolic heart failure.
    Izumida T; Imamura T; Ueno Y; Tanaka S; Kataoka N; Nakamura M; Kinugawa K
    Heart Vessels; 2021 Nov; 36(11):1688-1693. PubMed ID: 33956182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation.
    Dimopoulos S; Diakos N; Tseliou E; Tasoulis A; Mpouchla A; Manetos C; Katsaros L; Drakos S; Terrovitis J; Nanas S
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1607-14. PubMed ID: 21950763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2019 Oct; 26(5):405-411. PubMed ID: 31625118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The implication of optimal heart rate in patients with systolic dysfunction following TAVR.
    Imamura T; Tanaka S; Ushijima R; Sobajima M; Fukuda N; Ueno H; Besser S; Kinugawa K
    J Card Surg; 2021 Apr; 36(4):1328-1333. PubMed ID: 33538004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.
    Raina A; Seetha Rammohan HR; Gertz ZM; Rame JE; Woo YJ; Kirkpatrick JN
    J Card Fail; 2013 Jan; 19(1):16-24. PubMed ID: 23273590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blockade in Heart Failure With Reduced Ejection Fraction: Does Heart Rate Control Influence Readmissions?
    Owens RE; Twilla JD; Self TH; Alshaya AI; Metra CJ; Cummings C; Oliphant CS
    J Pharm Pract; 2018 Feb; 31(1):40-45. PubMed ID: 28737066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.
    Topilsky Y; Hasin T; Oh JK; Borgeson DD; Boilson BA; Schirger JA; Clavell AL; Frantz RP; Tsutsui R; Liu M; Maltais S; Kushwaha SS; Pereira NL; Park SJ
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):648-61. PubMed ID: 21940507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right ventricular response to pulsatile load is associated with early right heart failure and mortality after left ventricular assist device.
    Grandin EW; Zamani P; Mazurek JA; Troutman GS; Birati EY; Vorovich E; Chirinos JA; Tedford RJ; Margulies KB; Atluri P; Rame JE
    J Heart Lung Transplant; 2017 Jan; 36(1):97-105. PubMed ID: 27469015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial.
    Yau TM; Pagani FD; Mancini DM; Chang HL; Lala A; Woo YJ; Acker MA; Selzman CH; Soltesz EG; Kern JA; Maltais S; Charbonneau E; Pan S; Marks ME; Moquete EG; O'Sullivan KL; Taddei-Peters WC; McGowan LK; Green C; Rose EA; Jeffries N; Parides MK; Weisel RD; Miller MA; Hung J; O'Gara PT; Moskowitz AJ; Gelijns AC; Bagiella E; Milano CA;
    JAMA; 2019 Mar; 321(12):1176-1186. PubMed ID: 30912838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Hemodynamics During Left Ventricular Assist Device Support Are Associated With Reduced Readmission Rates.
    Imamura T; Jeevanandam V; Kim G; Raikhelkar J; Sarswat N; Kalantari S; Smith B; Rodgers D; Besser S; Chung B; Nguyen A; Narang N; Ota T; Song T; Juricek C; Mehra M; Costanzo MR; Jorde UP; Burkhoff D; Sayer G; Uriel N
    Circ Heart Fail; 2019 Feb; 12(2):e005094. PubMed ID: 30704291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying Temporal Relationships Between In-Hospital Adverse Events After Implantation of Durable Left Ventricular Assist Devices.
    Kilic A; Seese L; Pagani F; Kormos R
    J Am Heart Assoc; 2020 Apr; 9(8):e015449. PubMed ID: 32285751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Hemodynamic Ramp Test-Guided HVAD Speed and Medication Adjustments on Clinical Outcomes.
    Uriel N; Burkhoff D; Rich JD; Drakos SG; Teuteberg JJ; Imamura T; Rodgers D; Raikhelkar J; Vorovich EE; Selzman CH; Kim G; Sayer G
    Circ Heart Fail; 2019 Apr; 12(4):e006067. PubMed ID: 30946600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal cannula positioning of HeartMate 3 left ventricular assist device.
    Imamura T; Narang N; Nitta D; Fujino T; Nguyen A; Kim G; Raikhelkar J; Rodgers D; Ota T; Jeevanandam V; Sayer G; Uriel N
    Artif Organs; 2020 Dec; 44(12):e509-e519. PubMed ID: 32557769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular assist improves autonomic imbalance in patients with persistent myocardial dysfunction.
    Gardiwal A; Roentgen P; Luesebrink U; Koenig T; Klein G; Oswald H
    Int J Artif Organs; 2010 Dec; 33(12):851-5. PubMed ID: 21186466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.